General Information
Version
6
Revision date
2024-12-01
Product name
Flowpatch Deepfill
1.2.1 Relevant identified uses
Consumer Industrial Professional
1.2.2. Uses advised against
Reason
Emergency telephone
+353 19014670
Icons in SDS
Company Information
company name
Watco UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
info@watco.fr, info@watco.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Precautionary statements
General P103 - Read carefully and follow all instructions. P102 - Keep out of reach of children. P101 - If medical advice is needed, have product container or label at hand.
Prevention
P280 - Wear protective gloves. Wear eye or face protection.
Response
Not applicable.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
Cement, portland, chemicals
Supplemental label elements
Not applicable. elements Not applicable. elements Detergents - Regulation (EC) No 907/2006
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
May form explosible dust-air mixture if dispersed.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Eye Irrit. 2, H319 Skin Sens. 1, H317 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
